New immunisation reference page: Tetanus prone wounds management
Tetanus, also known as lockjaw, is a serious bacterial infection caused by the bacteria Clostridium tetani. Tetanus causes severe muscle spasms and can be fatal. The bacteria live in soil, dust and animal faeces. Tetanus can be prevented by vaccination.
For further information and immunisation recommendations please refer to MVEC’s new immunisation reference page: टेटनस प्रवण घाव प्रबंधन
ATAGI statement on use of Dengvaxia® for Australians
The Australian Technical Advisory Group on Immunisation (ATAGI) has
developed advice for immunisation providers regarding the administration of
Dengvaxia® for Australians. It includes information about the dengue virus, as
well as use, efficacy and safety of the dengue vaccine in Australians.
Dengvaxia® is potentially harmful and should not be used in
people who have never had a dengue infection.
https://www.health.gov.au/news/clinical-advice-atagi-statement-on-use-of-dengvaxiar-for-australians
Victoria's chief health officer is warning pregnant women to protect their unborn babies with the flu vaccination
Hundreds of Victorian babies have been diagnosed with the flu, prompting health authorities to warn pregnant mothers to check their vaccinations are up to date.
Early bird tickets now available for the November CVU!
The next Clinical Vaccinology Update (CVU) will be held on Monday 25th November 2019. Hosted by our Monash Health team, this event will be held in the Exhibition Space H116, at Monash University Caulfield, just off Princes Avenue.
Tickets are now available and for those of you who book prior to 31st August, you will receive the early bird price of $100 per ticket!
The program for this event is yet to be announced, however information will be displayed on आयोजन page as soon as it is made available.
Zoster vaccine resources
Administration of Zostavax® (zoster vaccine) in individuals who are immunocompromised is contraindicated due to the risk of causing disseminated disease. Prior to immunisation, and in conjunction with the pre-immunisation checklist, द Zostavax® GP Decision Aid should be completed to ensure patient safety. For further information on Zostavax®, please refer to the updated links below:
MVEC: Zostavax® GP Decision Aid
MVEC: Zoster vaccine (Zostavax®) FAQs
Good news for childhood immunisation rates in Australia!
The latest immunisation coverage rates are showing a national figure of almost 95% of Australian 5-year olds being fully immunised, with the coverage rate for Aboriginal and Torres Strait Islander children leading the way with close to 97%
The Guardian, July 7, 2019: Immunisation rates for Australian children reaches record 95%
New podcast with Katrina Clark now available!
MVEC's latest podcast is now available!
In this episode, Katrina Clark discusses her role as the National Indigenous Immunisation Coordinator, the importance of immunisation for the Aboriginal and Torres Strait Islander community, as well as what we can do to enhance coverage in this group.
To begin listening please follow the link below:
Episode 3: Katrina Clark- immunising Aboriginal and Torres Strait Islander communities
New immunisation reference page- Guillain-Barre Syndrome
Guillain-Barre Syndrome is an autoimmune condition resulting in muscle weakness, altered sensation, numbness and paralysis. It is often triggered by a viral or bacterial infection however there is also variable evidence suggesting an association with influenza vaccination.
For further information and immunisation recommendations please refer to MVEC's new immunisation reference page
Influenza vaccine 2019- FAQ's
MVEC's Frequently Asked Questions for the 2019 Influenza season are now available online
To view our reference page please click on the following link:
MVEC: Influenza vaccine- Frequently asked questions
Avoiding shoulder injury related to vaccine administration
Shoulder injury related to vaccine administration (SIRVA) describes a complication of incorrect immunisation technique whereby a vaccine is injected too high above the deltoid muscle. Implications of SIRVA include persisting pain and limited range of movement, uncertain seroprotection due to the incorrect site of administration, as well costly outcomes for the patient due to diagnostic imaging and interventions.. For tips on avoiding SIRVA please refer to the following resources:
MVEC: Shoulder injury related to vaccine administration
एमवीईसी: इंजेक्शन वाले टीकों का प्रशासन- सही तकनीक
Australian Immunisation Handbook: avoiding shoulder injury related to vaccine administration